Key Takeaways
- • Abry Partners closed a $780 million continuation vehicle for Centauri Health Solutions, an oversubscribed fund that extends the firm's ownership stake in the healthcare platform.
- • The continuation fund was co-led by Neuberger Private Markets and Apollo's Sponsor and Secondary Solutions business, signaling strong institutional backing for the extension.
- • The structure provided existing limited partners with liquidity options while simultaneously raising fresh committed capital for continued operational development and growth initiatives.
- • The transaction reflects sustained investor appetite for established healthcare software and services platforms, particularly those with demonstrated operational performance.
Summary
Abry Partners has successfully closed a $780 million continuation vehicle designed to extend its investment partnership with Centauri Health Solutions. The oversubscribed fund represents a common private equity strategy in which sponsors retain ownership of a mature portfolio company while offering existing investors the dual benefit of partial liquidity and re-investment opportunities in a freshly capitalized vehicle.
The continuation fund attracted significant institutional co-investment from Neuberger Private Markets and Apollo's Sponsor and Secondary Solutions business, both of which served as co-lead investors. This combination of anchor investors underscores institutional confidence in both the Centauri platform and Abry's operational stewardship. The participation of Apollo's secondary and sponsor solutions arm is particularly noteworthy, as it reflects the growing trend of large institutional capital providers seeking exposure to mature, cash-generative healthcare assets through continuation structures rather than traditional secondary acquisitions.
The transaction structure afforded existing limited partners the strategic choice between taking liquidity at the fund level or maintaining continued exposure to Centauri's growth trajectory through re-commitments into the new vehicle. This optionality is standard in continuation vehicles and serves as a mechanism for aligning long-term investor interests while enabling those requiring near-term capital distributions to exit portions of their positions.
Centauri Health Solutions, the underlying portfolio company, operates within the healthcare technology and services sector—an area that has maintained consistent institutional investor interest due to favorable demographic tailwinds and recurring revenue characteristics. The successful close of the continuation vehicle at this scale suggests that operational and financial performance metrics have justified extended private equity ownership beyond the typical 5-7 year fund lifecycle.
The continuation fund attracted significant institutional co-investment from Neuberger Private Markets and Apollo's Sponsor and Secondary Solutions business, both of which served as co-lead investors. This combination of anchor investors underscores institutional confidence in both the Centauri platform and Abry's operational stewardship. The participation of Apollo's secondary and sponsor solutions arm is particularly noteworthy, as it reflects the growing trend of large institutional capital providers seeking exposure to mature, cash-generative healthcare assets through continuation structures rather than traditional secondary acquisitions.
The transaction structure afforded existing limited partners the strategic choice between taking liquidity at the fund level or maintaining continued exposure to Centauri's growth trajectory through re-commitments into the new vehicle. This optionality is standard in continuation vehicles and serves as a mechanism for aligning long-term investor interests while enabling those requiring near-term capital distributions to exit portions of their positions.
Centauri Health Solutions, the underlying portfolio company, operates within the healthcare technology and services sector—an area that has maintained consistent institutional investor interest due to favorable demographic tailwinds and recurring revenue characteristics. The successful close of the continuation vehicle at this scale suggests that operational and financial performance metrics have justified extended private equity ownership beyond the typical 5-7 year fund lifecycle.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.